MicroRNA-384-5p regulates ischemia-induced cardioprotection by targeting phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta (PI3K p110δ)

Apoptosis

Volumn 18, Issue 3, 2013, Pages 260-270

  Bao, Yanyan ^a   Lin, Chengren ^a   Ren, Junguo ^a   Liu, Jianxun ^a  

^a XIYUAN HOSPITAL   (China)

Author keywords

Cardiomyocytes; Cardioprotection; Hypoxia; microRNA; Myocardialischemia

Indexed keywords

CASPASE 3; LUCIFERASE; MICRORNA; MICRORNA 384 5P; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE 3 KINASE; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE 3 KINASE CATALYTIC SUBUNIT DELTA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BINDING SITE; BIOINFORMATICS; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; DENSITY; DOWN REGULATION; GENE TARGETING; HEART MUSCLE ISCHEMIA; HEART PROTECTION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; CASPASE 3; CELL LINE; CELL SURVIVAL; DOWN-REGULATION; MICRORNAS; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; PHOSPHATIDYLINOSITOL 3-KINASES; PROTEIN ARRAY ANALYSIS; RATS; RATS, WISTAR; UP-REGULATION;

RATTUS;

EID: 84877138291     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-013-0802-1     Document Type: Article

References (25)

1. Mackman N (2008) Triggers, targets and treatments for thrombosis. Nature 451:914-918
2. Bernardo BC, Weeks KL, Pretorius L, McMullen JR (2010) Molecular distinction between physiological and pathological cardiac hypertrophy: experimental findings and therapeutic strategies. Pharmacol Ther 128:191-227
3. Matsui T, Rosenzweig A (2005) Convergent signal transduction pathways controlling cardiomyocyte survival and function: the role of PI 3-kinase and Akt. J Mol Cell Cardiol 38:63-71
4. Fruman DA, Meyers RE, Cantley LC (1998) Phosphoinositide kinases. Annu Rev Biochem 67:481-507
5. Toker A, Cantley LC (1997) Signalling through the lipid products of phosphoinositide-3-OH kinase. Nature 387:673-676
6. Crackower M, Oudit G, Kozieradzki I, Sarao R, Sun H, Sasaki T et al (2002) Regulation of myocardial contractility and cell size by distinct PI3K-PTEN Signaling pathways. Cell 110:737
7. Lin RCY, Weeks KL, Gao X-M, Williams RBH, Bernardo BC, Kiriazis H, Matthews VB, Woodcock EA, Bouwman RD, Mollica JP, Speirs HJ, Dawes IW, Daly RJ, Shioi T, Izumo S, Febbraio MA, Du X-J, McMullen JR (2010) PI3K(p110α) protects against myocardial infarction-induced heart failure: identification of PI3K-regulated miRNA and mRNA. Arterioscler Thromb Vasc Biol 30:724-732
8. Oudit GY, Crackower MA, Eriksson U, Sarao R, Kozieradzki I, Sasaki T et al (2003) Phosphoinositide 3-kinase gamma-deficient mice are protected from isoproterenol-induced heart failure. Circulation 108:2147-2152
9. Cuellar TL, McManus MT (2005) MicroRNAs and endocrine biology. J Endocrinol 187:327-332
10. Wright GW, Simon RM (2003) A random variance model for detection of differential gene expression in small microarray experiments. Bioinformatics 19:2448-2455
11. Yang H, Crawford N, Lukes L, Finney R, Lancaster M, Hunter KW (2005) Metastasis predictive signature profiles pre-exist in normal tissues. Clin Exp Metastasis 22:593-603
12. Clarke R, Ressom HW, Wang A, Xuan J, Liu MC, Gehan EA, Wang Y (2008) The properties of high-dimensional data spaces: implications for exploring gene and protein expression data. Nat Rev Cancer 8:37-49
13. Gene Ontology Consortium (2006) The gene ontology (GO) project in 2006. Nucleic Acids Res 34:D322-D326
14. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, Harris MA, Hill DP, Issel-Tarver L, Kasarskis A, Lewis S, Matese JC, Richardson JE, Ringwald M, Rubin GM, Sherlock G (2000) Gene ontology: tool for the unification of biology. The gene ontology consortium. Nat Genet 25(1):25-29
15. Dupuy D, Bertin N, Hidalgo CA, Venkatesan K, Tu D, Lee D, Rosenberg J, Svrzikapa N, Blanc A, Carnec A, Carvunis AR, Pulak R, Shingles J, Reece-Hoyes J, Hunt-Newbury R, Viveiros R, Mohler WA, Tasan M, Roth FP, Le Peuch C, Hope IA, Johnsen R, Moerman DG, Barabasi AL, Baillie D, Vidal M (2007) Genome-scale analysis of in vivo spatiotemporal promoter activity in Caenorhabditis elegans. Nat Biotechnol 25:663-668
16. Kanehisa M, Goto S, Kawashima S, Okuno Y, Hattori M (2004) The KEGG resource for deciphering the genome. Nucleic Acids Res 32:D277-D280
17. Yi M, Horton JD, Cohen JC, Hobbs HH, Stephens RM (2006) WholePathwayScope: a comprehensive pathway-based analysis tool for high-throughput data. BMC Bioinformatics 7:30
18. Draghici S, Khatri P, Tarca AL, Amin K, Done A, Voichita C, Georgescu C, Romero R (2007) A systems biology approach for pathway level analysis. Genome Res 17:1537-1545
19. Song XW, Li Q, Lin L (2010) MiRNAs are dynamically regulated in hypertrophic hearts, and miR-199a is essential for the maintenance of cell size in cardiomyocytes. J Cell Physiol 225:437-443
20. D'Alessandra Y, Pompilio G, Capogrossi MC (2012) MicroRNAs and myocardial infarction. Curr Opin Cardiol 27(3):228-235
21. Thum T, Galuppo P, Wolf C, Fiedler J, Kneitz S, van Laake LW, Doevendans PA, Mummery CL, Borlak J, Haverich A, Gross C, Engelhardt S, Ertl G, Bauersachs J (2007) MicroRNAs in the human heart: a clue to fetal gene reprogramming in heart failure. Circulation 116:258-267
22. Mann DL (2007) MicroRNAs and the failing heart. N Engl J Med 356:2644-2645
23. Cheng Y, Ji R, Yue J, Yang J, Liu X, Chen H, Dean DB, Zhang C (2007) MicroRNAs are aberrantly expressed in hypertrophic heart: do they play a role in cardiac hypertrophy? Am J Pathol 170:1831-1840
24. D'Alessandra Y, Pompilio G, Capogrossi MC (2012) MicroRNAs and myocardial infarction. Curr Opin Cardiol 27(3):228-235
25. Fang J, Song XW, Tian J, Chen HY, Li DF, Wang JF, Ren AJ, Yuan WJ, Lin L (2012) Overexpression of microRNA-378 attenuates ischemia-induced apoptosis by inhibiting caspase-3 expression in cardiac myocytes. Apoptosis 17(4):410-423